Skip to main content

Table 5 In vivo assessment of the antioxidant activities of Fumaria officinalis on CAT levels in serum, alterations in TBARS and reduced GSH (Mean ± S.E.M., n = 7/group)

From: Niosomes of active Fumaria officinalis phytochemicals: antidiabetic, antineuropathic, anti-inflammatory, and possible mechanisms of action

Group

Dose (mg/kg)

Catalase level (kU/I)

TBARS Level (nM/100 g)

GSH (µg/mg)

Predose

8th week

Predose

8th week

Predose

8th week

NC

–

30.77 ± 1.66

30.20 ± 1.44

0.73 ± 0.02

0.75 ± 0.02

64.40 ± 1.10

64.83 ± 1.50

DC

–

21.28 ± 1.20

19.82 ± 1.48

1.15 ± 0.02

3.60 ± 0.03

57.30 ± 1.70

47.72 ± 1.40

GBa

5

21.42 ± 1.11

22.17 ± 1.36

1.17 ± 0.02

1.78 ± 0.04

56.70 ± 1.60

56.53 ± 1.50

FOa

50

21.66 ± 1.44

35.50 ± 1.25*

0.98 ± 0.01

0.58 ± 0.02*

59.90 ± 1.50

64.9 ± 1.50*

FOa

100

21.98 ± 1.23

37.80 ± 1.43*

1.02 ± 0.01

0.56 ± 0.03*

59.00 ± 1.60

65.11 ± 1.30*

FOa

200

21.85 ± 1.55

40.50 ± 1.37*

1.00 ± 0.02

0.54 ± 0.04*

61.58 ± 1.30

65.50 ± 1.40*

ARFa

15

22.19 ± 1.15

38.65 ± 1.55*

0.97 ± 0.02

0.53 ± 0.01*

60.98 ± 1.40

65.55 ± 1.40*

ARFa

30

21.28 ± 1.78

39.56 ± 1.70*

1.00 ± 0.02

0.45 ± 0.01*

62.85 ± 1.20

66.50 ± 1.10*

ARFa

60

22.49 ± 1.57

43.65 ± 1.31*

0.96 ± 0.01

0.40 ± 0.02*

62.11 ± 1.30

70.50 ± 1.10*

Stya

7.5

21.42 ± 1.25

30.50 ± 1.45*

1.15 ± 0.02

0.97 ± 0.03*

60.60 ± 1.20

59.34 ± 1.30*

Stya

15

21.29 ± 1.11

32.50 ± 1.34*

1.02 ± 0.02

0.95 ± 0.03*

61.83 ± 1.50

59.90 ± 1.40*

Stya

30

21.89 ± 1.45

33.65 ± 1.05*

0.97 ± 0.01

0.93 ± 0.01*

60.13 ± 1.70

60.11 ± 1.50*

Sana

7.5

22.29 ± 1.15

31.52 ± 1.13*

1.00 ± 0.03

0.93 ± 0.03*

59.75 ± 1.60

60.22 ± 1.80*

Sana

15

21.28 ± 1.18

31.59 ± 1.56*

1.02 ± 0.02

0.89 ± 0.02*

61.74 ± 1.20

60.25 ± 1.90*

Sana

30

22.51 ± 1.16

32.90 ± 1.50*

0.98 ± 0.01

0.85 ± 0.02*

61.17 ± 1.50

61.44 ± 1.70*

Nio 1a

60

22.70 ± 1.78

37.56 ± 1.77*

0.92 ± 0.02

0.45 ± 0.02*

59.66 ± 1.40

63.22 ± 1.40*

Nio 2a

60

22.90 ± 1.34

46.25 ± 1.45*

1.22 ± 0.02

0.34 ± 0.02*

59.77 ± 1.21

75.55 ± 1.10*

Nio 3a

60

21.97 ± 1.56

39.56 ± 1.33*

0.89 ± 0.01

0.46 ± 0.02*

59.34 ± 1.33

65.66 ± 1.10*

Nio 4a

60

22.56 ± 1.77

33.58 ± 1.45*

0.94 ± 0.02

0.50 ± 0.01*

59.83 ± 1.54

62.99 ± 1.40*

Nio 5a

60

22.89 ± 1.44

35.65 ± 1.55*

1.01 ± 0.01

0.48 ± 0.02*

60.13 ± 1.70

65.55 ± 1.30*

Nio 6a

60

22.48 ± 1.35

34.60 ± 1.45*

0.90 ± 0.01

0.56 ± 0.01*

60.75 ± 1.55

63.88 ± 1.40*

Placebo Ia

–

22.45 ± 1.33

20.22 ± 1.22

1.11 ± 0.01

1.30 ± 0.04

62.98 ± 1.40

60.00 ± 1.30*

Placebo IIa

–

22.56 ± 1.77

19.20 ± 1.46

1.22 ± 0.02

1.45 ± 0.04

62.55 ± 1.41

59.33 ± 1.20*

  1. S.E.M. mean standard error
  2. * p < 0.05 significant from the vehicle control animals
  3. aCompared to vehicle control